LCBI Awards Its First Low-Carbon Labels in Germany and Belgium to The Stack in Munich and Luxia in Brussels
8.9.2025 15:42:00 EEST | Business Wire | Press release
The Low Carbon Building Initiative (LCBI), launched in 2022 by major European real estate players and BBCA (the Association for the Development of Low Carbon Buildings), presents two new international labels in Brussels and in Munich at SIBCA, the low-carbon real estate trade fair, which took place from 3rd to 5th September in Paris.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908685544/en/
The Stack, timber offices in Munich
The Stack, timber offices in Munich
AXA IM Alts launched the construction of ‘The Stack,’ a c. 17,100 sqm timber hybrid office asset in the centre of Munich. The scheme, designed by Wilmotte & Associés Architectes and implemented by RKW Architektur +, aims to achieve market-leading environmental credentials, combining a sustainably sourced timber-hybrid construction method with green energy technology and biophilic design features.
Overall, the strategy has allowed to drastically reduce the project’s carbon footprint compared to a typical new-build development, reaching the ”Excellent” level of LCBI label at design stage.
Low-carbon construction materials were used with approx. 1,800 cubic meters of spruce wood from Austria, with an amount of 325.5 kg CO2e/m² embodied carbon (30% less than DGNB-certified solid construction).
The building is also supplied with district cooling and heating from Munich's municipal utilities and uses the best technologies, reaching 8.27 kg CO2e/m² in Operational Carbon, i.e. 40% less compared to the DGNB benchmark.
Advanced smart building technology, including CO₂ sensors, variable ventilation systems and intelligent lighting controls, regulates indoor air quality and supports enhanced workplace productivity and wellbeing.
Luxia, low carbon offices connected to Brussels city center
Luxia is a prime, low-carbon office building developed by AXA IM Alts. Designed by the Brussels-based architects DDS+, the recently delivered state-of-the-art 13.000 sqm (GFA) building has been developed in line with circularity principles. Luxia is built on preserved foundations and re-uses many materials and the concrete of the demolished building, allowing for a drastic reduction in carbon footprint of its construction phase.
Conceived as a pioneering low-carbon project, Luxia is the first project to receive the LCBI Certificate in Belgium, reaching the LCBI Performance level at delivery. Having achieved the highest possible score on all ESG-performance metrics, it is recognized as one of the most sustainable buildings in Brussels, certified as BREEAM Outstanding, WELL Gold, PEB A, Airscore A, Wiredscore Gold, and the labels Fossil-Free and Biodiversity.
With the ambition to minimize the overall carbon footprint of the project, Luxia has managed to reduce Co2 emissions on all phases of the building’s life cycle. The carbon footprint of the construction phase, measured on full scope, is limited to 931 kgCO2e/m² (50yr) and the annual operational carbon to a very low 11,2 kgCO2e/m². The energy consumption has been drastically lowered to 48 kWh/m²/year, by using heat pumps, solar energy and a comprehensive smart building approach.
“The Luxia project benefits from a strong location and is positioned as a high-quality product on the Brussels market, with large outdoor terraces, low energy consumption and a wide range of first-rate business services. Luxia is a Green Trophy Asset for our client, and will, as a future proof building, fully contribute to our ambitious ESG-strategy. The LCBI-certification process enabled us to keep a 360° view as from the design phase. Also, it allowed us to maintain a coherent grasp of the interests of our client, the end-user and for the future of the asset.”
— Marc Kramer, Head of Development Benelux, AXA IM Alts
“The Stack offers the opportunity to meet demand for high-end, ESG-oriented, well-connected office space in downtown Munich, just two minutes from the central station. With delivery scheduled for early 2026, the pre-lease rate of around 60% reflects the appeal of our flexible and collaborative office concept, which is attracting forward-thinking users. As the first LCBI-certified office building in Germany, this project affirms our commitment to sustainability and has been designed to meet the evolving needs of demanding tenants and align with our global investment principles."
— Filipe de Sá Pessoa, Head of Development Germany, AXA IM Alts
“We are delighted to award two new certifications in Brussels and in Munich, extending the LCBI footprint already established in Milan, Paris and Belval (Luxemburg). We are showing that the progress of real estate decarbonization in Europe relies on close collaboration with local stakeholders, at each step of a building project. We are proud that our technical expertise is sufficiently well-recognized in Europe to attract the interest of major players in the real estate sector such as AXA IM Alts. It is a matter of considerable pride for us to see that these companies have demonstrated their commitment to decarbonization and their confidence in our technology.”
— Cécile DAP, LCBI Director
... Some figures from BBCA, the association behind the LCBI initiative, revealed at SIBCA on the same day in France:
- In 2025, 2.25 million m² were committed to or certified by BBCA (compared to 1.55 million in 2024 and 1.48 million in 2023). New builds account for 43% of production.
- In just one year, BBCA has certified nearly 700,000 m², an increase of nearly 100% compared to 2024.
- Since 2016, BBCA applications in progress or certifications have exceeded 5.7 million m² (compared to 4.55 million in 2024), corresponding to 760 projects in 2025 (compared to 630 in 2024).
About LCBI
The Low Carbon Building Initiative was launched in 2022 by major players in the real estate sector (Generali Real Estate, Covivio, BPI Real Estate, BNP Paribas Real Estate, Bouygues Immobilier, WO2, Icamap, NSI, Ivanhoé Cambridge and AXA IM Alts) and BBCA (the Association for the Development of Low-Carbon Buildings). Its aim is to develop the low-carbon certification of real estate projects in Europe in order to hasten the decarbonisation of the sector. Based on key European standards and benchmarks, the LCBI methodology serves to standardise the practice of life-cycle analysis (ACV) throughout Europe. The LCBI label, audited by Bureau Veritas and CERTIVEA, takes account of the complete life cycle of buildings, and measures the carbon footprint as well as the comprehensiveness of the ACV on three levels: grey carbon (emissions associated with construction) measured in kgCO2e/sq.m over 50 ans, carbon from use (linked to consumption and energy sources) measured in kgCO2e/sq.m./year, and the measurement of biogenic carbon storage contained in the building measured in kgCO2e/sq.m. The label has three performance levels: Standard, Performance and Excellence.
https://www.lowcarbonbuilding.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250908685544/en/
Contacts
PRESS
LES ROIS MAGES | clemence.mayrand-freynet@lesroismages.fr (+33 6 28 04 21 98)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX ® , a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain15.9.2026 14:30:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX® (suzetrigine), a prescription non-opioid medicine for the treatment of moderate-to-severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in January 2025, JOURNAVX marked the first new class of pain medicine in over 20 years — since then JOURNAVX has been prescribed to over one million Americans. During the 2026 Winter Games in Milano Cortina, Lindsey suffered a serious crash during her downhill race. The fall resulted in multiple injuries that required immediate surgery and several additional procedures. Now, Lindsey is sharing her story and her personal experience treating her moderate-to-severe acute pain with JOURNAVX. “I have experienced countless injuries throughout my career, and I’m no stranger to the pain that comes along with them. After my injury at the 2026 Olympic Winter Games,
Kinaxis Advances Operational Orchestration Vision with Agentic AI at Kinexions EMEA 202615.9.2026 14:00:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in AI-powered supply chain planning and orchestration, will bring together some of the world’s most innovative supply chain leaders at Kinexions EMEA 2026 from October 26-28. Building on the operational orchestration vision Kinaxis introduced earlier this year, the conference offers an inside look at how leading organizations are harnessing AI innovation and agentic capabilities to help supply chain leaders make better decisions, coordinate action across the business and drive measurable outcomes. From AI Potential to Operational Impact As organizations continue to invest heavily in AI, many struggle to translate intelligence into action - just 12% of supply chain leaders consider themselves AI leaders, despite widespread deployment of AI capabilities. Kinaxis CEO Razat Gaurav and Executive Vice President, EMEA, Fabienne Cêtre, will open the mainstage with an exploration of the market forces reshaping global supply chains and how operational orc
Cebreo Medical Receives CE Mark for NeuroBuds®, a Discreet In-Ear, Medical-Grade EEG Wearable for Extended Ambulatory Monitoring15.9.2026 14:00:00 EEST | Press release
Cebreo Medical today announced that its NeuroBuds® device has received CE marking, confirming conformity with applicable EU requirements. Unlike conventional EEG systems that require a technician-applied cap of electrodes, NeuroBuds is designed to be used unassisted by the patient at home, enabling multi-day and multi-night recordings in a patient's daily life environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914704547/en/ NeuroBuds(TM), EarEEG “With NeuroBuds, we can offer a discreet, unobtrusive solution that enables long-term, unassisted EEG monitoring for weeks, in patients’ own homes. The product has the potential to significantly reduce the cost of long-term EEG monitoring and strengthen treatment decisions compared with conventional brain monitoring.” — Rasmus Madsen, CEO, Cebreo Medical Designed to resemble a hearing aid, NeuroBuds is built to minimize the stigma and burden that typically limit complianc
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 202615.9.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression and is designed to help navigate care pathways for patients and providers. Change the Tune in TRD was developed to provide evidence-based education to U.S. HCPs on the longer, more persistent episodes associated with TRD, alongside cognitive and emotional patterns, including getting stuck in negative or repetitive ways of thinking, difficulty shifting perspective or navigating emotions, and feeling disconnected from pleasure or motivation1-8. While TRD originates as MDD, its burden and resistance to standard treatments distinguish it as a more complex condition. Compared to MDD, TRD patients experience almost 3x long
NIQ Launches Digital Purchase GeoAudiences Across Europe15.9.2026 13:00:00 EEST | Press release
NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including travel, automotive, technology, telecommunications and financial services. The launch expands NIQ’s GeoPurchase offering, which currently provides syndicated audiences across 13 international markets. Digital Purchase GeoAudiences address growing demand from advertisers for purchase-informed audience intelligence across a broader range of digital-first industries and shopping environments. By combining NIQ’s digital commerce intelligence with its GeoPurchase framework, the solution helps advertisers identify geographic areas showing stronger digital shopping activity. Marketers can use these signals to inform where they plan and prioritize media investment. “Marketers shouldn’t have to guess where demand is coming from before they invest,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom